ALXN - Alexion Pharmaceuticals, Inc.

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by T0rm3nted, Jun 6, 2016.

  1. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,145
    Likes Received:
    2,974
    [​IMG]
    Alexion Pharmaceuticals, Inc. (ALXN) is a biopharmaceutical company. The Company is focused on the development and commercialization of life-transforming therapeutic products. The Company operates through innovation, development and commercialization of life-transforming therapeutic products segment. The Company's marketed products include Soliris (eculizumab), Strensiq (asfotase alfa) and Kanuma (sebelipase alfa). The Company's clinical programs include Soliris (eculizumab), ALXN 1101, ALXN 1007, SBC-103, ALXN 1210 and ALXN 5500. It offers Soliris for patients with either paroxysmal nocturnal hemoglobinuria (PNH), a life-threatening and ultra-rare genetic blood disorder, or atypical hemolytic uremic syndrome (aHUS), a life-threatening and ultra-rare genetic disease. Strensiq is a targeted enzyme replacement therapy. It offers Kanuma for the treatment of patients with Lysosomal Acid Lipase Deficiency (LAL-D). ALXN 1007 is a humanized antibody designed to target inflammatory disorders.
     
  2. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,145
    Likes Received:
    2,974
    Alexion Announces Phase 3 Trial Failure; Shares Down 9% In After-Hours Trade
    Shares of Alexion Pharmaceuticals (ALXN) are down 9% in after-hours trade after the company announced that it had failed a phase 3 trial. The phase 3 trial, known as the REGAIN study, was testing the company's drug Soliris in patients with refractory generalized myasthenia gravis (refractory gMG.)

    Read full article here: http://www.talkmarkets.com/content/...shares-down-9-in-after-hours-trade?post=96535
     
  3. anotherdevilsadvocate

    anotherdevilsadvocate Well-Known Member

    Joined:
    Apr 3, 2016
    Messages:
    3,518
    Likes Received:
    2,767
    Weekly chart:
    [​IMG]

    MACD as low as it'll go. Price fell through the bottom of the channel but momentum didn't fall as far. Purple moving average shown is the 20-week (currently +10% from price).
     
  4. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,145
    Likes Received:
    2,974
    Recent Insider Trading:

    upload_2016-11-8_1-25-2.png
    upload_2016-11-8_1-25-25.png
     
  5. anotherdevilsadvocate

    anotherdevilsadvocate Well-Known Member

    Joined:
    Apr 3, 2016
    Messages:
    3,518
    Likes Received:
    2,767
    Keeping an eye on this one. I guess currently in biotech-land there's something called the ASH conference.

    [​IMG]
     
    StockJock-e likes this.
  6. Gambit

    Gambit Active Member

    Joined:
    Oct 16, 2016
    Messages:
    703
    Likes Received:
    63
    Alexion Pharmaceuticals says CEO, CFO resigns
    Dec 12 Alexion Pharmaceuticals Inc said on Monday that Chief Executive David Hallal had resigned, effective immediately, and named board member David Brennan as interim CEO.
    The company also said Chief Financial Officer Vikas Sinha left to pursue other opportunities, effective immediately, and would be succeeded by David Anderson, who was earlier CFO at Honeywell International Inc.

    http://in.reuters.com/article/alexion-pharms-moves-ceo-idINL4N1E73G8
     
  7. LloydWCoutee

    LloydWCoutee Active Member

    Joined:
    May 4, 2016
    Messages:
    721
    Likes Received:
    58
    $ALXN watching top rev out gate or under 113.
     
  8. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    8,876
    Likes Received:
    3,142
    Sell off overdone?
     
  9. fidelgeorge

    fidelgeorge Well-Known Member

    Joined:
    Apr 15, 2016
    Messages:
    971
    Likes Received:
    393
    Drug company Alexion Pharmaceuticals (ALXN) is also likely to move higher after reaffirming its full-year earnings and sales guidance.
     
  10. Gambit

    Gambit Active Member

    Joined:
    Oct 16, 2016
    Messages:
    703
    Likes Received:
    63
    Alexion Pharmaceuticals on the Recovery Trail $ALXN
    [​IMG]
     
  11. LloydWCoutee

    LloydWCoutee Active Member

    Joined:
    May 4, 2016
    Messages:
    721
    Likes Received:
    58
    Oppenheimer Gives a Hold Rating to Alexion Pharmaceuticals $ALXN
     
  12. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    8,876
    Likes Received:
    3,142
    Todays pharma mover is... ALXN!
     
  13. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    8,876
    Likes Received:
    3,142
    Alexion shares jump 11% premarket on news of positive trial of treatment for rare blood disorder
     
  14. anotherdevilsadvocate

    anotherdevilsadvocate Well-Known Member

    Joined:
    Apr 3, 2016
    Messages:
    3,518
    Likes Received:
    2,767
    Been in a range for 2 years with a nice spring, just started peeking through declining tops line. Think this one is ready to move.
    [​IMG]
     
    T0rm3nted likes this.
  15. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,145
    Likes Received:
    2,974
    The bullish crossover of the MA's would support your theory as well.

    upload_2018-7-6_17-3-28.png
     
    Stockaholic likes this.

Share This Page